ART debuts new optical molecular imaging unit

By staff writers

May 17, 2007 -- Canadian optical molecular imaging developer ART Advanced Research Technologies has launched eXplore Optix MX2, an optical molecular imaging device for drug development applications.

The system is designed to improve workflow efficiency while providing a richer dataset through advanced data collection and analysis, according to the Montreal-based firm. eXplore Optix MX2 employs time-domain technology, which allows for the detection of signals at lower concentrations that are deeper inside the body, ART said.

The system also includes a CT fusion software package.

By staff writers
May 17, 2007

ART's revenues slip in 2006, March 26, 2007

ART lands CE Mark, February 8, 2007

ART, GE extend eXplore Optix pact, December 22, 2006

ART gets Health Canada approval for SoftScan, December 14, 2006

ART completes financing, corporate reorganization, November 29, 2006

Copyright © 2007


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking